[Recurrent vulvovaginitis: diagnostic assessment and therapeutic management] (Q80930562)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18358194%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

title

[Recurrent vulvovaginitis: diagnostic assessment and therapeutic management] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18358194%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18358194%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

Ramírez-Santos A

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18358194%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Toribio J

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18358194%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

publication date

1 April 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18358194%20AND%20SRC:MED&resulttype=core&format=json

Actas Dermo-Sifiliográficas

4 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18358194%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

99

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18358194%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18358194%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

190-198

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18358194%20AND%20SRC:MED&resulttype=core&format=json

Epidemiology of vaginitis

4 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

Vaginitis: meeting the clinical challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

Vaginal discharge--causes, diagnosis, and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

Difficult-to-manage vaginitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

A pilot study of metronidazole vaginal gel versus oral metronidazole for the treatment of Trichomonas vaginalis vaginitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

Clinical practice. Acute vulvovaginitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

Difficult-to-treat trichomoniasis: results with paromomycin cream.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

Recalcitrant vaginal trichomoniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

Bacterial vaginosis: review of treatment options and potential clinical indications for therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

The diagnosis and treatment of infectious vaginitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

Managing recurrent bacterial vaginosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

The incidence of genitourinary infections in a cohort of healthy women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

7 January 2021

Vulvovaginal candidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

Evaluation and management of vaginitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

Vaginal candidosis: epidemiological and etiological factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

History and update on host defense against vaginal candidiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

Itraconazole in the treatment of acute and recurrent vulvovaginal candidosis: comparison of a 1-day and a 3-day regimen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

Chronic fungal vaginitis: the value of cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

Vulvovaginal carriage of yeasts other than Candida albicans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

Prevalence of and risk factors for fungal vaginitis caused by non-albicans species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

Recurrent vaginal candidiasis. Importance of an intestinal reservoir

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

Karyotyping of Candida albicans isolates obtained longitudinally in women with recurrent vulvovaginal candidiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

New immunotherapeutic strategies to control vaginal candidiasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

The serum levels of calcium, magnesium, iron and zinc in patients with recurrent vulvovaginal candidosis during attack, remission and in healthy controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

Identification of yeasts in public hospital primary care patients with or without clinical vaginitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

Impaired tolerance for glucose in women with recurrent vaginal candidiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

Vaginal colonization by bacteria and yeast.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

Sexual behavior of women with repeated episodes of vulvovaginal candidiasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

Aerobic and anaerobic flora of the cervix during pregnancy and the puerperium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

Association between atopy and recurrent vaginal candidiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

Chronic vaginal candidiasis in women with human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

Immunopathogenesis of recurrent vulvovaginal candidiasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

Post-menopausal recurrent vaginal candidiasis: effect of hysterectomy on response to treatment, type of colonization and recurrence rates post-treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

Vaginal microbial flora in normal young women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

7 January 2021

Vulvovaginal candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

Treatment options for vulvovaginal candidiasis, 1993.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

Vulvovaginitis. When Candida becomes a problem.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

Gynecologic care for women with HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

Cross-Resistance of clinical isolates of Candida albicans and Candida glabrata to over-the-counter azoles used in the treatment of vaginitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

Treatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

Probiotics for prevention of recurrent vulvovaginal candidiasis: a review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

7 January 2021

Vaginal lactobacillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

7 January 2021

Allergic vulvovaginitis

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

Cutaneous hypersensitivity to Candida albicans in idiopathic vulvodynia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

Allergic contact dermatitis and vulvar dermatoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2808%2974655-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0001-7310(08)74655-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18358194%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference